Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing physician shortage in medically underserved rural and tribal communities through residency program collaboration.

Journal of osteopathic medicine·2026
Same author

Disparities in osteoarthritis diagnosis and symptoms between English- and Spanish-speaking Latinas over 40 years of age in the United States: a analysis of the Behavioral Risk Factor Surveillance System.

Ethnicity & health·2023
Same author

The Enneagram and its application in medical education.

Proceedings (Baylor University. Medical Center)·2022
Same author

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.

The Lancet. Respiratory medicine·2021
Same author

Spin Infrequently Occurs in Abstracts of Systematic Reviews For The Pharmacological Treatment of Type 2 Diabetes Mellitus.

Diabetic medicine : a journal of the British Diabetic Association·2021
Same author

The fragility of randomized trial outcomes underlying management of dyspepsia and Helicobacter pylori infections.

International journal of evidence-based healthcare·2019
Same journal

Beyond timing: mobility may be the missing variable in venous thromboembolism prevention after traumatic brain injury.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Beyond comorbidity scores: medication burden as a window into surgical risk following ankle fracture fixation.

Proceedings (Baylor University. Medical Center)·2026
Same journal

The risk of primary lung cancer in ANCA-associated vasculitis: systematic review and meta-analysis.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Clinical presentation and treatment of a case of anti-signal recognition particle-positive immune-mediated necrotizing myopathy.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Nationwide analysis of adult nongonococcal native septic knee arthritis hospitalizations from 2016 to 2022.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Comparing the diagnostic performance of 19-gauge and 22-gauge needles in endoscopic ultrasound-guided liver biopsy: a systematic review and meta-analysis.

Proceedings (Baylor University. Medical Center)·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Primary hyperparathyroidism and pregnancy.

Mousumi Som1, Jeffrey S Stroup

  • 1Department of Medicine, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.

Proceedings (Baylor University. Medical Center)
|July 9, 2011
PubMed
Summary
This summary is machine-generated.

Primary hyperparathyroidism, a common endocrine disorder, can complicate pregnancy. This case highlights severe maternal and fetal issues arising from hyperparathyroidism during pregnancy, particularly with pre-existing hypertension.

More Related Videos

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Related Experiment Videos

Last Updated: May 31, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Area of Science:

  • Endocrinology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Primary hyperparathyroidism is a prevalent endocrine disorder, affecting women twice as often as men.
  • Hyperparathyroidism during pregnancy presents significant risks, with maternal complication rates reaching 67%.
  • This condition can exacerbate pre-existing maternal health issues like chronic hypertension.

Purpose of the Study:

  • To present a case of primary hyperparathyroidism in pregnancy.
  • To illustrate the exacerbation of chronic hypertension in a pregnant patient with primary hyperparathyroidism.
  • To discuss the sequelae for both mother and fetus.

Main Methods:

  • Case report presentation.
  • Review of patient history including diagnosis and management.
  • Discussion of maternal and fetal outcomes.

Main Results:

  • A pregnant patient with chronic hypertension experienced worsening hypertension.
  • Concomitant diagnosis of primary hyperparathyroidism was established.
  • Adverse maternal and fetal outcomes were observed due to the combined conditions.

Conclusions:

  • Primary hyperparathyroidism poses substantial risks during pregnancy.
  • The interplay between hyperparathyroidism and chronic hypertension can lead to severe complications.
  • Prompt diagnosis and management are crucial for maternal and fetal well-being.